Literature DB >> 11002603

Can varying concepts of susceptibility in risk assessment affect particulate matter standards?

R T Parkin1, J M Balbus.   

Abstract

The Clean Air Act mandates that sensitive subpopulations be considered in setting standards to protect the public's health. The purposes of this paper are to point out different conceptualizations of susceptibility, examine how it is approached in risk-related processes, and recommend ways it may be more explicitly framed for risk assessment and management purposes. We studied the traditional risk assessment paradigm, the U.S. Environmental Protection Agency (EPA) guidelines and revised PM standard, discussions from recent interdisciplinary meetings, and peer-reviewed literature. Areas of controversy include what factors intrinsic and extrinsic to the host should be incorporated in susceptibility, what health endpoints are of concern, whether susceptibility is deterministic or stochastic, and whether it should be defined on an individual or population scale. Recent discussions about susceptibility applied to PM indicate that it needs to be more clearly defined and evaluated for scientific and policy purposes. We conclude that varying concepts of susceptibility can affect risk-related processes such as PM standard setting. We recommend that susceptibility be clearly defined in the problem statement of risk assessments and be addressed in a specific subsection of risk characterization, integrating all susceptibility findings from the prior three steps in the risk assessment paradigm.

Mesh:

Year:  2000        PMID: 11002603     DOI: 10.1080/10473289.2000.10464181

Source DB:  PubMed          Journal:  J Air Waste Manag Assoc        ISSN: 1096-2247            Impact factor:   2.235


  1 in total

1.  Fine particulate matter national ambient air quality standards: public health impact on populations in the northeastern United States.

Authors:  Philip R S Johnson; John J Graham
Journal:  Environ Health Perspect       Date:  2005-09       Impact factor: 9.031

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.